Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$177.73
+0.4%
$175.77
$136.30
$182.38
$19.84B0.49994,306 shs1.21 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$74.38
-0.6%
$70.60
$57.65
$94.80
$34.06B1.143.51 million shs6.67 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$65.01
-0.2%
$60.00
$51.90
$84.67
$14.49B0.552.37 million shs3.32 million shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$24.14
+0.2%
$23.72
$20.61
$31.57
$23.24B0.76897,432 shs758,921 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.00%-0.88%+2.69%+4.93%+29.85%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%+4.35%+6.32%-7.84%-4.54%
Hologic, Inc. stock logo
HOLX
Hologic
0.00%+0.82%+4.69%+5.25%-12.44%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.00%+8.37%+4.77%-4.94%-4.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4.901 of 5 stars
2.34.04.24.73.42.51.9
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
4.1571 of 5 stars
3.43.01.70.03.51.72.5
Hologic, Inc. stock logo
HOLX
Hologic
4.7427 of 5 stars
3.24.00.04.33.63.31.3
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
3.5665 of 5 stars
0.05.01.70.02.50.03.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.69
Moderate Buy$185.734.50% Upside
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.83
Moderate Buy$88.2718.68% Upside
Hologic, Inc. stock logo
HOLX
Hologic
2.41
Hold$77.4219.08% Upside
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
3.00
BuyN/AN/A

Current Analyst Ratings Breakdown

Latest PHG, HOLX, GEHC, and DGX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/13/2025
Hologic, Inc. stock logo
HOLX
Hologic
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$77.00 ➝ $70.00
5/6/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.00
5/6/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$86.00 ➝ $78.00
5/5/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral$74.00 ➝ $73.00
5/5/2025
Hologic, Inc. stock logo
HOLX
Hologic
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$77.00 ➝ $65.00
5/2/2025
Hologic, Inc. stock logo
HOLX
Hologic
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$75.00 ➝ $70.00
5/2/2025
Hologic, Inc. stock logo
HOLX
Hologic
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$90.00 ➝ $71.00
5/2/2025
Hologic, Inc. stock logo
HOLX
Hologic
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$65.00 ➝ $62.00
5/2/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/1/2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$94.00 ➝ $82.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$9.87B2.01$13.50 per share13.17$61.38 per share2.90
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$19.67B1.73$5.78 per share12.87$18.53 per share4.01
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.59$5.50 per share11.82$22.09 per share2.94
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$19.50B1.19$3.10 per share7.79$13.86 per share1.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$871M$7.9122.4716.942.488.81%15.11%6.65%7/22/2025 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.99B$4.7515.6614.302.5111.02%24.95%6.38%7/30/2025 (Estimated)
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3727.4314.072.3813.83%19.71%10.87%8/4/2025 (Estimated)
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-$758.55M$0.4356.1412.510.682.11%10.97%4.57%7/29/2025 (Estimated)

Latest PHG, HOLX, GEHC, and DGX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.56N/AN/AN/A$2.73 billionN/A
5/6/2025Q1 2025
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.14$0.27+$0.13$0.09$4.10 billion$4.31 billion
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
4/30/2025Q1 2025
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.91$1.01+$0.10$1.23$4.66 billion$4.78 billion
4/22/2025Q1 2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.201.80%N/A40.46%14 Years
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.19%N/A2.95%1 Years
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.823.40%N/A190.70%N/A

Latest PHG, HOLX, GEHC, and DGX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/14/2025
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.801.86%7/7/20257/7/20257/21/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.84
1.44
1.31
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.73
0.98
0.76
Hologic, Inc. stock logo
HOLX
Hologic
0.54
3.24
2.52
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.60
1.28
0.79

Institutional Ownership

CompanyInstitutional Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
13.67%

Insider Ownership

CompanyInsider Ownership
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
8.16%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.27%
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
56,000111.64 million102.53 millionOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
53,000457.89 million456.65 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.85 million218.66 millionOptionable
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
66,678962.92 millionN/AOptionable

Recent News About These Companies

PHG Koninklijke Philips N.V. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$177.73 +0.67 (+0.38%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$175.08 -2.65 (-1.49%)
As of 06/27/2025 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$74.38 -0.48 (-0.64%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$74.57 +0.19 (+0.25%)
As of 06/27/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Hologic stock logo

Hologic NASDAQ:HOLX

$65.01 -0.10 (-0.15%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$64.93 -0.08 (-0.12%)
As of 06/27/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Koninklijke Philips stock logo

Koninklijke Philips NYSE:PHG

$24.14 +0.06 (+0.25%)
Closing price 06/27/2025 03:59 PM Eastern
Extended Trading
$24.14 +0.00 (+0.02%)
As of 06/27/2025 05:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.